Endstage heart failure affects over 2 × 106 people worldwide, of which 15,000 to 60,000 would benefit from a heart transplant [1,2]. Ventricular Assist Devices (VADs) increase survival rates when waiting on the heart transplant list [1,2] but cannot be powered by an implantable battery alone due to the high energy demand of a blood pump. This is most often accomplished by a percutaneous power cable. The insertion site of the cable is prone to infection due to compromise of the skin's ability to act as a barrier to pathogens; ∼20% of patients with VADs develop driveline infections [1,2]. The driveline could be eliminated altogether if power were transferred wirelessly to the internal device.

Coil/coil transcutaneous energy transfer system (TETS) have been used to provide power to these devices [3]....

References

References
1.
Spelman
,
D.
, and
Esmore
,
D.
,
2012
, “
Ventricular Assist Device Infections
,”
Curr. Infect. Dis. Rep.
,
14
(4), pp.
359
366
.10.1007/s11908-012-0261-9
2.
Gordon
,
R.
,
Quagliarello
,
B.
, and
Lowy
,
F.
,
2006
, “
Ventricular Assist Device-Related Infections
,”
Lancet Infec. Diseases
,
6
(7), pp.
426
437
.10.1016/S1473-3099(06)70522-9
3.
Mussivand
,
T.
,
2008
, “
Mechanical Circulatory Support Devices: Is It Time to Focus on the Complications, Instead of Building Another New Pump?
Artif Organs
,
32
(
1
), pp.
1
4
.10.1111/j.1525-1594.2007.00518.x
4.
Hanzlik
,
E.
,
Day
,
S.
,
Duncan
,
C.
,
Diaw
,
A.
,
Blaszczynski
,
P.
,
Christopher
,
A.
,
Brown
,
M.
,
Hladky
,
A.
,
Turner
,
A.
,
Pickard
,
K.
,
Borton
,
C.
, and
Dominick
,
I.
,
2014
, “P13021: Transcutaneous Energy Transfer System,” Rochester Institute of Technology, Rochester, NY, available at: http://edge.rit.edu/content/P13021/public/Home
You do not currently have access to this content.